Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

D'Addario C

142 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-06-30Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-18Therapeutic advances in fibromyalgia: one year in review 2026.Unknown journal · 2026-06-16Reorganization of Human Brain Waves Across Diverse States of ConsciousnessbioRxiv · 2026-05-31Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-09Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-04-30Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-29Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelicsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-03-27Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military PersonnelJournal of Police and Criminal Psychology · 2026-03-22Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)Journal of Psychoactive Drugs · 2026-03-155 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.Unknown journal · 2026-03-04Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-02-28Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development ResearchDigital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law) · 2026-02-11Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effectsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-02-11Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.The International journal on drug policy · 2026-01-31The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-01-13The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-21Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14Legal and Regulatory Barriers to Medical Psilocybin Use: An International OverviewUnknown journal · 2025-10-01Emerging mechanisms of psilocybin-induced neuroplasticity.Unknown journal · 2025-09-14Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-CompassionResearch Square · 2025-08-21Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder AnalysisResearch Square · 2025-08-18Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Unknown journal · 2025-08-14Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma SymptomsPsychiatry and Clinical Psychopharmacology · 2025-08-13Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.Unknown journal · 2025-07-07Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed NeuroimagingbioRxiv · 2025-07-02Exploring serotonergic psychedelics as a treatment for personality disorders.Neuropharmacology · 2025-06-30Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Unknown journal · 2025-06-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.Unknown journal · 2025-06-29Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-17Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health TreatmentJournal of Psychoactive Drugs · 2025-05-28The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in RodentsACS Pharmacology & Translational Science · 2025-05-28Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic StudyJournal of Integrative and Complementary Medicine · 2025-05-26Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2025-04-21Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Unknown journal · 2025-04-21Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and BehaviourbioRxiv · 2025-04-13Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-20Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online AccountsJournal of Psychoactive Drugs · 2025-02-28Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Unknown journal · 2025-01-29Molecular Phylogeny and Morphology Reveal Four New Species of Conocybe (Bolbitiaceae, Agaricales) from the Qinghai-Xizang Plateau, China.Unknown journal · 2025-01-05Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblastsBiochemistry and Cell Biology · 2024-12-31Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.Frontiers in pharmacology · 2024-12-31Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Human brain changes after first psilocybin usebioRxiv · 2024-10-13Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcomenpj Mental Health Research · 2024-10-05Usage of Psilocybin to Treat Huntington's Disease: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-09-04Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Unknown journal · 2024-07-31Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-23Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used PsilocybinCannabis and Cannabinoid Research · 2024-06-16Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-06-09Therapeutic Implications of Psilocybin in the Wake of DecriminalizationIntegrative and Complementary Therapies · 2024-05-31Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Unknown journal · 2024-05-30Psychedelic therapy in depression and substance use disorders.Unknown journal · 2024-05-20Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogensPsychiatry and Clinical Neurosciences Reports · 2024-05-15Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-12Structural pharmacology and therapeutic potential of 5-methoxytryptamines.Unknown journal · 2024-05-07Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanismsMolecular Psychiatry · 2024-04-26Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot studyScientific Reports · 2024-02-06Do the therapeutic effects of psilocybin involve actions in the gut?Trends in Pharmacological Sciences · 2024-01-10Rapid-acting antidepressant drugs modulate affective bias in rats.Unknown journal · 2024-01-08Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female ratsNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Unknown journal · 2023-12-31Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-25Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-25Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent ratsTranslational Psychiatry · 2023-12-13Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Unknown journal · 2023-11-29Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphereAuthorea Preprints · 2023-11-16Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06Perceptions of psychedelic-assisted therapy among Black AmericansJournal of Mood and Anxiety Disorders · 2023-09-25Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Psilocybin history, action and reaction: A narrative clinical review.Unknown journal · 2023-08-30The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility StudyClinicalTrials.gov · 2023-07-26A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-17509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09In silico characterization of the psilocybin biosynthesis pathwayComputational Biology and Chemistry · 2023-03-22Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.Unknown journal · 2023-03-16The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Mescaline: The forgotten psychedelic.Unknown journal · 2022-10-13Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network Neuroscience · 2022-09-30Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-19The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus · 2022-08-31To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and Clinical Psychopharmacology · 2022-08-31Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.Unknown journal · 2022-08-11The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-06A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-06-30The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Unknown journal · 2022-04-25Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Psilocybin-Assisted Compassion Focused Therapy for Depression.Frontiers in Psychology · 2022-03-24The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.Frontiers in psychiatry · 2021-12-31P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.Unknown journal · 2021-11-16Case Report: Magic Mushroom (Psilocybe Cubensis) IntoxicationArchives of The Medicine and Case Reports · 2021-10-12Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and Clinical Psychopharmacology · 2021-06-06Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-19Psilocybin and MDMA for the treatment of trauma-related psychopathology.Unknown journal · 2021-04-30Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Psilocybin, Spirituality, and Palliative Care: Research and ImplicationsAlternative and Complementary Therapies · 2021-01-12Investigation of the Structure-Activity Relationships of Psilocybin AnaloguesACS Pharmacology & Translational Science · 2020-12-13Historic psychedelic drug trials and the treatment of anxiety disorders.Depression and anxiety · 2020-11-30[Addictions].Unknown journal · 2019-12-30Psilocybin-assisted therapy for depression: How do we advance the field?Australian & New Zealand Journal of Psychiatry · 2019-11-21Decreased Directed Functional Connectivity in the Psychedelic StatebioRxiv · 2019-07-15Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.Experimental and Clinical Psychopharmacology · 2019-01-09Biological Effects and Biodistribution of Bufotenine on Mice.Unknown journal · 2018-05-30"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and Cannabinoid Research · 2018-02-28The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07A New Spectrophotometric Method for the Determination of Psilocin and PsilocybinInternational Journal of Analytical and Applied Chemistry · 2016-12-31Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of Psychopharmacology · 2016-11-30Enhanced repertoire of brain dynamical states during the psychedelic experience.Human Brain Mapping · 2014-07-02Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Journal of Neuroscience · 2011-01-31The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Salvia divinorum use and phenomenology: results from an online survey.Unknown journal · 2010-10-10Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-16Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.Unknown journal · 2009-12-09Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.Oxidative Medicine and Cellular Longevity · 2009-08-31Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of Clinical Psychiatry · 2006-10-31Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of Cognitive Neuroscience · 2005-09-30The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31Identifying the presence of ‘magic mushrooms’ by DNA profilingScience & Justice · 2001-12-31Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.Unknown journal · 2000-10-31The problem of psilocybin mushroom abuse.Unknown journal · 1982-09-30

Author directory

Carhart-Harris RL.61 publicationsRobin Carhart-Harris57 publicationsCarhart-Harris R52 publicationsVollenweider FX52 publicationsNutt DJ51 publicationsGriffiths RR50 publicationsJohnson MW46 publicationsErritzoe D44 publicationsRoseman L42 publicationsBarrett FS.35 publicationsDavid Erritzøe34 publicationsDavid Nutt34 publicationsPreller KH34 publicationsKnudsen GM33 publicationsJohns Hopkins University31 publicationsNutt D28 publicationsRoland R. Griffiths28 publicationsHendricks PS27 publicationsGarcia-Romeu A25 publicationsFranz X. Vollenweider24 publicationsGitte M. Knudsen24 publicationsRosenblat JD24 publicationsFisher PM23 publicationsKatrin H. Preller23 publicationsAlbert Garcia-Romeu22 publicationsPatrick M. Fisher22 publicationsPáleníček T.22 publicationsSandeep M. Nayak22 publicationsTomáš Páleníček22 publicationsDea Siggaard Stenbæk21 publicationsMatthew W. Johnson21 publicationsTimmermann C21 publicationsDavis AK20 publicationsFrederick S. Barrett20 publicationsMcIntyre RS20 publicationsYaden DB20 publicationsJames Rucker19 publicationsKargbo RB.19 publicationsLiechti ME19 publicationsStenbæk DS19 publicationsDeco G18 publicationsDirk Hoffmeister18 publicationsDos Santos RG18 publicationsHusain MI18 publicationsM. Madsen18 publicationsNathan D. Sepeda18 publicationsOzenne B18 publicationsRoss S18 publicationsGonzález-Maeso J.17 publicationsGuy M. Goodwin17 publicationsKringelbach ML.17 publicationsKuypers KPC.17 publicationsMadsen MK17 publicationsSeifritz E17 publicationsSimonsson O17 publicationsBrice Ozenne16 publicationsFischer R.16 publicationsHannes Kettner16 publicationsKwan AC.16 publicationsYale University16 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsMason NL.15 publicationsMatthias E. Liechti15 publicationsNayak SM15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsAlan K. Davis14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKim P. C. Kuypers14 publicationsKometer M14 publicationsManish Agrawal14 publicationsMuhammad Ishrat Husain14 publicationsWang X14 publicationsBasel13 publicationsDavid J. Hellerstein13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsMcCulloch DE13 publicationsNatasha L. Mason13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsBarnett BS.12 publicationsBenyamina A12 publicationsDavid B. Yaden12 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsHolze F12 publicationsJoshua Woolley12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMartin Kuchař12 publicationsPeter S. Hendricks12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsStephen Ross12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsAlexander M. Sherwood11 publicationsBouso JC.11 publicationsFriederike Holze11 publicationsGouzoulis-Mayfrank E11 publicationsKaelen M11 publicationsLeor Roseman11 publicationsMichael P. Bogenschutz11 publicationsNichols CD.11 publicationsOsika W11 publicationsRoger S. McIntyre11 publicationsSchmid Y11 publicationsScott T. Aaronson11 publicationsAnderson BT10 publicationsCharles D. Nichols10 publicationsChristopher Timmermann10 publicationsDavoudian PA10 publications